[5-(4-Chloro-phenyl)-4-cyclopentylmethyl-2-(2-ethoxy-4-methoxy-phenyl)-4,5-dihydro-imidazol-1-yl]-(4-methyl-piperazin-1-yl)-methanone → [5-(4-Chloro-phenyl)-2-(2-ethoxy-4-methoxy-phenyl)-4-propyl-4,5-dihydro-imidazol-1-yl]-(4-methyl-piperazin-1-yl)-methanone
반응식
ClC1C=CC(C2NC(C3C=CC(OC)=CC=3OCC)=NC2CCC)=CC=1.[Cl:27][C:28]1[CH:33]=[CH:32][C:31]([CH:34]2[N:38]([C:39]([N:41]3[CH2:46][CH2:45][N:44]([CH3:47])[CH2:43][CH2:42]3)=[O:40])[C:37]([C:48]3[CH:53]=[CH:52][C:51]([O:54][CH3:55])=[CH:50][C:49]=3[O:56][CH2:57][CH3:58])=[N:36][CH:35]2[CH2:59][CH:60]2CCC[CH2:61]2)=[CH:30][CH:29]=1>>[Cl:27][C:28]1[CH:33]=[CH:32][C:31]([CH:34]2[N:38]([C:39]([N:41]3[CH2:46][CH2:45][N:44]([CH3:47])[CH2:43][CH2:42]3)=[O:40])[C:37]([C:48]3[CH:53]=[CH:52][C:51]([O:54][CH3:55])=[CH:50][C:49]=3[O:56][CH2:57][CH3:58])=[N:36][CH:35]2[CH2:59][CH2:60][CH3:61])=[CH:30][CH:29]=1참가 물질
3
반응물 2
생성물 1
실험 절차
[5-(4-Chloro-phenyl)-2-(2-ethoxy-4-methoxy-phenyl)-4-propyl-4,5-dihydro-imidazol-1-yl]-(4-methyl-piperazin-1-yl)-methanone was prepared from 5-(4-chloro-phenyl)-2-(2-ethoxy-4-methoxy-phenyl)-4-propyl-4,5-dihydro-1H-imidazole (Example 18) in an analogous manner as described for the preparation of [5-(4-chloro-phenyl)-4-cyclopentylmethyl-2-(2-ethoxy-4-methoxy-phenyl)-4,5-dihydro-imidazol-1-yl]-(4-methyl-piperazin-1-yl)-methanone (Example 24). HR-MS (ES, m/z) observed 499.2477, calculated for C27H36N4O3Cl [(M+H)+]499.2471.